SCHEMBL6497937

SCHEMBL6497937

COc1cc(C(=O)NC[C@H](NC(=O)C2CCN(C(=O)/C=C/c3ccc(SC)c(Cl)c3Cl)CC2)C(=O)O)cc(OC)c1OC

nearest known ligand 0.49

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ITGAL P20701 9/20 0.49
ITGB2 P05107 7/20 0.49
ICAM1 P05362 7/20 0.49
KDM4E B2RXH2 2/20 0.40
ALDH1A1 P00352 1/20 0.40
HPGD P15428 1/20 0.40
NPC1 O15118 1/20 0.39
APOBEC3A P31941 1/20 0.39
RAB9A P51151 1/20 0.39
APOBEC3G Q9HC16 1/20 0.39
CAPN1 P07384 3/20 0.38
TP53 P04637 1/20 0.38
ABCB1 P08183 1/20 0.36
TSHR P16473 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6497963 1.00 ITGAL (0.49) ITGALITGB2ICAM1KDM4EALDH1A1
SCHEMBL6497948 1.00 ITGAL (0.49) ITGALITGB2ICAM1KDM4EALDH1A1
SCHEMBL6509099 0.93 ITGAL (0.49) ITGALITGB2ICAM1KDM4EALDH1A1
SCHEMBL6509091 0.93 ITGAL (0.49) ITGALITGB2ICAM1KDM4EALDH1A1
SCHEMBL6509111 0.93 ITGAL (0.49) ITGALITGB2ICAM1KDM4EALDH1A1
SCHEMBL6498029 0.91 ITGAL (0.47) ITGALITGB2ICAM1ALDH1A1NPC1
SCHEMBL6498043 0.91 ITGAL (0.47) ITGALITGB2ICAM1ALDH1A1NPC1
SCHEMBL6498020 0.91 ITGAL (0.47) ITGALITGB2ICAM1ALDH1A1NPC1
SCHEMBL6497168 0.89 ITGAL (0.48) ITGALITGB2ICAM1ALDH1A1NPC1
SCHEMBL6497150 0.89 ITGAL (0.48) ITGALITGB2ICAM1ALDH1A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005016883-A2 ACRYLAMIDE DERIVATIVES AS VLA-1 INTEGRIN ANTAGONISTS AND USES THEREOF ICOS CORPORATION (US) 2005-02-24 WO claimed
WO-2005016883-A2 ACRYLAMIDE DERIVATIVES AS VLA-1 INTEGRIN ANTAGONISTS AND USES THEREOF ICOS CORPORATION (US) 2005-02-24 WO disclosed